Voriconazole versus Amphotericin B for Primary Therapy of Invasive AspergillosisRaoul Herbrecht, Ben de Pauw, David W. Denning et al.|New England Journal of Medicine|2002Cited by 3.3k
Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC StudiesMaurizio Brausi, Richard Sylvester, A P van der Meijden et al.|European Urology|2002Cited by 682
EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-GuérinSamantha Cambier, Jorg R. Oddens, Richard Sylvester et al.|European Urology|2015Cited by 639
Key Steps in Conducting Systematic Reviews for Underpinning Clinical Practice Guidelines: Methodology of the European Association of UrologyThomas Knoll, Richard Sylvester, Muhammad Imran Omar et al.|European Urology|2017Cited by 225
“Classical” CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancerE Engelsman, Richard Sylvester, J.C.M. Klijn et al.|European Journal of Cancer and Clinical Oncology|1991Cited by 165